Table 1. Changes in CK2 gene expression in lung cancer.

Gene	P-Value	Fold Change	Rank (Top %)	Dataset	#Samples	Reference
Squamous Cell Carcinoma
CK2α	1.5 10−7	18.9	1%	Bhattacharjee	203	[58]
	2.3 10−13	2.2	2%	Hou	156	[59]
CK2α'	5.2 10−6	1.8	2%	Garber	73	[60]
	0.01	2.4	10%	Bhattarcharjee	203	[58]
	9.9 10−4	1.5	4%	Yamagata	31	[61]
CK2αP	0.01	2.1	15%	Garber	73	[60]
Adenocarcinoma
CK2α	0.001	3.3	3%	Bhattarcharjee	203	[58]
	5.0 10−18	1.4	1%	Okayama	246	[62]
	3.1 10−13	1.6	2%	Hou	156	[59]
CK2α'	1.1 10−6	1.5	1%	Garber	73	[60]
CK2β	3.6 10−9	1.5	2%	Beer	96	[63]
	8.5 10−6	1.6	13%	Talbot	93	[64]
LCLC
CK2α	2.4 10−9	2.5	1%	Hou	156	[59]
CK2β	8.2 10−5	1.5	11%	Hou	96	[59]
SCLC
CK2α	4.3 10−4	6	3%	Bhattarcharjee	203	[58]
Lung Carcinoid
CK2α	1.2 10−5	6.6	3%	Bhattarcharjee	203	[58]
CK2β	0.002	−2.6	39%	Bhattarcharjee	203	[58]

Different subtypes of lung cancer are analyzed and p-values, fold changes, and datasets are included.